EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of PAX7 in Breast Cancer Prognosis and Its Mechanistic Involvement in the Wnt/β‐Catenin Pathway

Qidong Ge, Wei Zhang, Chao Li, Xinlin Li, Zhen Wang iD, Xujun Li

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Qidong Ge und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, People's Republic of China. Hauptthemen laut MEDLINE: Breast Neoplasms, Wnt Signaling Pathway, PAX7 Transcription Factor. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Project of NINGBO Leading Medical & Health Discipline, the Medical and Health Plan of Zhejiang.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer significantly affects women's lives globally. While PAX7 (Paired Box 7), a regulatory protein linked to muscle growth, has been connected to various cancers, its role in breast cancer is not well understood. This study explores PAX7's significance in breast cancer and its mechanisms. RNA‐seq data from the TCGA database assessed PAX7 expression across cancer types. Prognostic value in breast cancer was evaluated using Kaplan–Meier and Cox regression analyses. Functional experiments, including high‐throughput sequencing, cell growth analysis, colony formation, Transwell assays, and Western blot analysis, were conducted on PAX7 knockdown cell lines (MDA‐MB‐468 and MDA‐MB‐231). Results showed high PAX7 expression in breast cancer linked to lower survival rates. PAX7 knockdown affected over 2000 genes and inhibited cancer cell proliferation, migration, and invasion, involving the Wnt/β‐catenin pathway. SKL2001 reversed these effects. PAX7 is a potential prognostic biomarker and therapeutic target, with elevated levels indicating a poor prognosis. Further research on PAX7‐targeted therapies is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsWnt Signaling PathwayPAX7 Transcription FactorHumansFemalePrognosisGene Expression Regulation, NeoplasticCell ProliferationCell Line, TumorBiomarkers, TumorCell MovementKaplan-Meier Estimatebeta Catenin

Stichwörter der Autor:innen

PAX7Wnt/β‐catenin pathwaymetastasisprognosisproliferation

Substanzen

PAX7 Transcription FactorBiomarkers, TumorPAX7 protein, humanbeta Catenin

Autor:innen und Institutionen

  • Department of Oncology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, People's Republic of China.
  • Department of Breast Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, People's Republic of China.
  • Department of Anesthesiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.

ORCID-Profile: Zhen Wang

Förderung

  • the Project of NINGBO Leading Medical & Health Discipline
  • the Medical and Health Plan of Zhejiang

Zitieren

APA

Ge, Q., Zhang, W., Li, C., Li, X., Wang, Z., & Li, X. (2025). The Role of PAX7 in Breast Cancer Prognosis and Its Mechanistic Involvement in the Wnt/β‐Catenin Pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70602

Vancouver

Ge Q, Zhang W, Li C, Li X, Wang Z, Li X. The Role of PAX7 in Breast Cancer Prognosis and Its Mechanistic Involvement in the Wnt/β‐Catenin Pathway. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70602

BibTeX
@article{Ge2025,
  author = {Ge, Qidong and Zhang, Wei and Li, Chao and Li, Xinlin and Wang, Zhen and Li, Xujun},
  title = {The Role of PAX7 in Breast Cancer Prognosis and Its Mechanistic Involvement in the Wnt/β‐Catenin Pathway},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70602}
}
Kostenlos starten →